China Pharma Holdings (CPHI) Deferred Taxes (2010 - 2018)
China Pharma Holdings (CPHI) reported Deferred Taxes of -$1195.0 for Q4 2018, down 103.91% on a YoY basis from $30525.0 in Q4 2017, and down 105.68% quarter-over-quarter from $21039.0 in Q3 2018.
China Pharma Holdings (CPHI) Deferred Taxes (2010 - 2018) Analysis & Trends
China Pharma Holdings has reported Deferred Taxes for 9 years, with the latest figure at -$1195.0 in Q4 2018.
- For the quarter ending Q4 2018, Deferred Taxes fell 103.91% year-over-year to -$1195.0; the trailing twelve-month figure through Dec 2018 stood at $68419.0 (down 44.21% YoY), and the FY2018 full-year result was $68419.0, down 44.21% from the prior year.
- Deferred Taxes for Q4 2018 stood at -$1195.0, down from $21039.0 in the prior quarter.
- The five-year high for Deferred Taxes was $421825.0 in Q3 2015, with the low at -$1195.0 in Q4 2018.
- Historically, Deferred Taxes has averaged $58385.9 across 5 years, with a median of $21039.0 in 2018.
- Annual changes were most pronounced in 2015 — Deferred Taxes soared 2095.29% — and 2018, when it sank 103.91%.
- China Pharma Holdings' Deferred Taxes stood at $19284.0 in 2014, then soared by 2087.44% to $421825.0 in 2015, then sank by 42.36% to $243131.0 in 2016, then sank by 87.45% to $30525.0 in 2017, then sank by 103.91% to -$1195.0 in 2018.
- The last three Deferred Taxes figures came in at -$1195.0 (Q4 2018), $21039.0 (Q3 2018), and $22590.0 (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -22.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 34.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 25.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 14,341.73 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -61.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -8.79 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 19.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -13.98 Mn |
| 10 | China Pharma Holdings | 19.13 Mn | 18.97 Mn | 285,487.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -1,195.00 |
| Sep 30, 2018 | 21,039.00 |
| Jun 30, 2018 | 22,590.00 |
| Mar 31, 2018 | 25,985.00 |
| Dec 31, 2017 | 30,525.00 |
| Sep 30, 2017 | 31,198.00 |
| Jun 30, 2017 | 30,574.00 |
| Mar 31, 2017 | 30,334.00 |
| Dec 31, 2016 | 243,131.00 |
| Sep 30, 2016 | 20,800.00 |
| Sep 30, 2015 | 421,825.00 |
| Jun 30, 2015 | 19,428.00 |
| Mar 31, 2015 | 19,284.00 |
| Dec 31, 2014 | 19,284.00 |
| Sep 30, 2014 | 19,215.00 |
| Jun 30, 2014 | 19,196.00 |
| Mar 31, 2014 | 19,347.00 |
| Dec 31, 2013 | 2.19 Mn |
| Sep 30, 2013 | -472,512.00 |
| Jun 30, 2013 | -688,755.00 |